Featured

Doc's note: Many of the best companies in the world are based in the United States. But if your portfolio is stuffed with American companies, you may be in a dangerous position. Far more so than you realize...

That's why I'm sharing an essay from Kim Iskyan, editor of Truewealth Asian Investment Daily. In it, he explains the dangers of "home-country bias" and why an internationally diversified portfolio is essential for investing success.
For many people, there's no place like home. It's familiar and comfortable. But for your portfolio, staying at home means taking on a lot more risk than you might realize.

A wave of new money – up to $100 billion – is about to flood one of the best income-producing sectors in the market...

It's one of the most exciting "special situations" I've uncovered in 10 years at Stansberry Research.

Doc's note: We first began publishing Retirement Millionaire Daily in October 2015. Since then, we've sent more than 200 issues to our readers.

We've also welcomed tens of thousands of new readers. So every Thursday this month, we're sending our favorite issues from October 2015. If you haven't read these issues, we hope you enjoy them. If you've already read them, use them as a refresher or share them with your friends and family.

Never forget... the medical industry is Big Business.

Behind every doctor is an administrator... someone whose job it is to go to meetings... type in billing codes... or "adjust" insurance claims.

One of my favorite companies in the world has a name everyone's familiar with... In fact, you probably have a handful of its products in your house right now.

Johnson & Johnson (NYSE: JNJ) was founded in 1886. Today, it's the world's most comprehensive maker of health care products. It serves consumer, pharmaceutical, medical-device, and diagnostic markets. It has more than 250 subsidiary companies operating in 60 countries.

It has leadership positions in at least 23 distinct global health-related markets. It dominates markets like blood-glucose monitoring, blood screening and typing, disposable contact lenses, insulin delivery, low-cal sweeteners, oral rinses, minimally invasive surgery devices, over-the-counter drugs, sutures, and wound care.

It makes everything from baby oil to medical devices. It has powerful brands in beauty products (like Neutrogena), first aid (like Band-Aid), oral care (like Listerine), and medicine (like Tylenol). And many of its products are either No. 1 or No. 2 in their global markets.

Johnson & Johnson is the world's largest medical-device company. It is the eighth-largest drug company in the world. It's the fifth-largest biotech company in the world. It has marketed more than 100 different prescription drugs. It has 43 drugs with more than $50 million in sales, 31 drugs with more than $100 million in sales, and seven drugs doing more than $1 billion in annual sales.

You may think that J&J is a stodgy, old dinosaur, but it's far from it. It has actually grown earnings per share 21% since 2012, more than double the rate of the S&P 500 as a whole. It's paying out 3.2% as its dividend – which has grown 7% over the past three years. And it has bought back more than $10 billion in shares in the last three years.

In its most recent earnings release, J&J posted year-over-year growth of 1.8% in earnings and 3.9% in sales in the last quarter.

And J&J's stock is relatively stable compared with the rest of the market. It has a "beta" of just 0.8, meaning its average moves are less severe than the overall market's. That makes J&J a great opportunity as a strong performer in a weak or even down market. That looks like a win-win to us.

Financially, Johnson & Johnson is like Microsoft. It's one of the safest companies you can invest in. Like Microsoft, J&J has a triple-A-rated balance sheet. That's as safe as it gets. J&J has more than $40 billion in cash and securities and about $23.6 billion in debt. Johnson & Johnson's net income covers its interest expense more than 46 times.

Johnson & Johnson has raised its dividend every year for the last 53 years in a row. Its dividend has grown at an average annual rate of 7.1% for the last three years, and I see no reason for growth to slow down much...

Nothing is forever.

Consider Kodak, the company in Rochester, New York.

Kodak was the Apple of its day. As the prime inventor of camera film, the company was on the constant edge of innovation. As late as the 1970s, it sold 90% of the film and 85% of the cameras in the U.S. But the end came fast for Kodak...

In 1995, digital cameras hit the consumer market... and almost immediately undermined Kodak's analog camera and film business. Ironically, the company had developed a digital camera as early as 1975, but didn't pursue it, realizing the threat it represented to its own film business.

By the time it got its digital business rolling, it was too late.

Editor's note: What should you do when the stock market isn't growing?

There's a type of investment that pays you more income than bonds and is safer than stocks. We're sharing an issue we originally published in May that details how this investment pays you even when stocks aren't rising.

Doc's note: What should you do with your money in a zero-percent-interest world? How can you generate income when savings accounts and Treasury securities are paying next to nothing?

In this issue of Retirement Millionaire Daily, I'm sharing an essay that my colleague Steve Sjuggerud wrote for his free DailyWealth e-letter that answers those questions. He explains why you can't always live off interest, and the best places to keep your money working for you right now.

Everywhere I went, the bears had me surrounded...

Last summer, I attended the Sprott Natural Resource Symposium in Vancouver, Canada. The conference was flush with knowledge on the mining and resource exploration business...

I get gold.

It feels good to have some gold coins hidden away in your basement safe. It's a thrill to hold something so valuable in your hand.